comparemela.com

Latest Breaking News On - Biosimilars awards - Page 1 : comparemela.com

Accord Healthcare wins four times at Global Generics Biosimilar Awards 2022

Accord Healthcare took home four awards, including Company of the Year, at the Global Generics and Biosimilars Awards, held in Frankfurt, Germany on

Paul tredwellCompany of the yearValue added medicine initiative of the yearBiosimilar initiative of the yearAccord healthcareGlobal genericsBiosimilars awardsBiosimilar initiativeValue added medicine initiativeRegulatory achievement

Investegate |Beximco Pharmaceut Announcements | Beximco Pharmaceut: Results for the 12-month period ended 30 June 2022

Investegate announcements from Beximco Pharmaceut, Results for the 12-month period ended 30 June 2022

United statesUnited kingdomEast timorFoster mitchellMohammad ali nawazMark brady andrewOxford astrazenecaAsia pacificVadim alexandre abigail wayneBeximco pharmaBeta cardone sotalolSm rabbur rezaBeximco pharmaceuticalsUnited kingdom companyBeximco pharmaceuticals limited pharmaOwners of the company

BioBlast w/e 04 Nov 22: dupilumab study, Accord cleans up at Global Generics and Biosimilars Awards, Amgen s Supreme Court petition for certioriari regarding enablement granted, AU tocilizumab COVID shortage measures lifted, Bio-Thera s secukinumab, Outlook s ophthalmic bevacizumab, Rani Therapeutics oral ustekinumab

Significant biosimilar activities this week include…

Sanofi regeneronSamsung bioepisCompany of the yearValue added medicine initiative of the yearBio thera solutionsUs supreme courtBiosimilar initiative of the yearSupreme courtFederal courtBiosimilars awardsGlobal genericsAdded medicine initiativeShanghai henlius biotechIntellectual property strategyHenlius biotechSupply only

Samsung Bioepis Wins Company of the Year, Asia-Pacific Award at the Global Generics & Biosimilars Awards 2022

Recognized and awarded for its leadership and expertise in biosimilars - following 2020 Biosimilar Initiative of the Year awardAlso shortlisted as finalists in Company of the Year, Regulatory Achievement

United statesYoon kimKostenloser wertpapierhandelChristopher hansung koJane chungSamsung bioepisCompany of the yearSamsung bioepis co ltdBiosimilar initiative of the yearRegulatory achievementBiosimilar initiativeGlobal genericsBiosimilars awardsBiosimilars awardChief executive officerBiosimilars award

Samsung Bioepis Wins Company of the Year, Asia-Pacific

Recognized and awarded for its leadership and expertise in biosimilars – following 2020 Biosimilar Initiative of the Year awardAlso shortlisted as.

United statesYoon kimChristopher hansung koJane chungSamsung bioepisCompany of the yearSamsung bioepis co ltdBiosimilar initiative of the yearRegulatory achievementBiosimilar initiativeGlobal genericsBiosimilars awardsBiosimilars awardChief executive officerBiosimilars award

vimarsana © 2020. All Rights Reserved.